A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors
Clinical trial NCT05941936 · UNKNOWN
Trial details
- NCT number
- NCT05941936
- Sponsor
- Suzhou BlueHorse Therapeutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2025-02-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.